Lee Dong Wook, Park Seok-Woo, Park Soo-Yeun, Heo Dae-Seog, Kim Kwang Hyun, Sung Myung-Whun
Department of Otorhinolaryngology-Head and Neck Surgery and Medical Research Institute, College of Medicine, Chungbuk National University, Cheongju, Korea.
Head Neck. 2004 Aug;26(8):706-15. doi: 10.1002/hed.20025.
Although cyclooxygenase-2 (COX-2) has been suggested to play an important role in carcinogenesis, the effects of tumor suppressors on COX-2 gene expression and the combined antitumor effects of tumor suppressors and COX-2 inhibitors have rarely been investigated.
The effects of p53 or p27 gene transfer on COX-2 expression by adenoviral vector and the combined effects of p53 or p27 gene transfer and COX-2 inhibitor exposure on the proliferation of cancer cells were investigated in head and neck squamous cell carcinoma (HNSCC) cell lines.
Overexpression of p53 markedly downregulated the transcription of COX-2, but the overexpression of p27 did not affect COX-2 levels in HNSCC cell lines. The combined antitumor effects of p53 or p27 gene transfer and of a COX-2 inhibitor (NS 398) were mainly at least additive in terms of the inhibition of cell proliferation and cell cycle arrest and additive in terms of apoptotic induction.
These results suggest that the overexpression of p53 could exert antitumor effects, at least in part, through the suppression of COX-2 gene expression, whereas growth suppression by the overexpression of p27 probably occurs by mechanisms other than the downregulation of COX-2 expression. In addition, the administration of COX-2 inhibitors, as an adjunct to p53 or p27 gene therapy, could offer a new strategy of cancer treatment and prevention.
尽管环氧合酶-2(COX-2)被认为在肿瘤发生过程中起重要作用,但肿瘤抑制因子对COX-2基因表达的影响以及肿瘤抑制因子与COX-2抑制剂的联合抗肿瘤作用鲜有研究。
在头颈部鳞状细胞癌(HNSCC)细胞系中,研究腺病毒载体介导的p53或p27基因转导对COX-2表达的影响,以及p53或p27基因转导与COX-2抑制剂联合作用对癌细胞增殖的影响。
p53的过表达显著下调COX-2的转录,但p27的过表达不影响HNSCC细胞系中COX-2的水平。就抑制细胞增殖和细胞周期阻滞而言,p53或p27基因转导与COX-2抑制剂(NS 398)的联合抗肿瘤作用主要至少是相加的,而就诱导凋亡而言是相加的。
这些结果表明,p53的过表达至少部分可通过抑制COX-2基因表达发挥抗肿瘤作用,而p27过表达引起的生长抑制可能通过下调COX-2表达以外的机制发生。此外,给予COX-2抑制剂作为p53或p27基因治疗的辅助手段,可能为癌症治疗和预防提供一种新策略。